Morehouse School of Medicine Officially welcomes the class of 2017

ATLANTA, Sept. 19, 2013 (GLOBE NEWSWIRE) -- The Morehouse School of Medicine (MSM) will induct 70 new MD students, 83% from Georgia, on Friday, September 20. MSM's Annual Convocation and White Coat Ceremony formally mark the start of medical education for a total of 129 students, including 59 in other advanced medical degree programs. The ceremony will begin at 10 a.m. in the auditorium of the National Center for Primary Care on the school's campus.

As MSM's largest MD class, students were carefully selected from a group of 4,767 applications - a record number for the medical school. They began orientation on Monday, July 1 and started classes Wednesday, July 3; 61 percent are women, while 39 percent are men.

Other programs began through out the fall with the following number of participants:

.

19 in Masters of Public Health .

6 Masters in Science in Clinical Research .

6 Ph.D. in Biomedical Sciences .

12 Masters of Science in Biomedical Research .

16 Masters of Science in Medical Sciences

MSM President John E. Maupin Jr., DDS, will address the students, their friends and family members about the importance of this day and the days ahead. During the ceremony, students will take their first oath of professional medical ethics, concluding with the words, "I commit myself to a lifelong journey of learning how to cure, relieve and comfort with humility and compassion."

See the original post:

Morehouse School of Medicine Officially welcomes the class of 2017

Genetics in Medicine publishes special issue dedicated to genomics in electronic health records

Public release date: 19-Sep-2013 [ | E-mail | Share ]

Contact: Kathy Ridgely Beal kbeal@acmg.net 301-238-4582 American College of Medical Genetics

September 19, 2013 Bethesda, MD Genetic tests can now tell us whether we are at increased risk of various cancers, heart or kidney disease, asthma and a number of other conditions.

Other genetic tests can tell whether you will respond to certain medicines or be harmed by side effects linked to your genetic code. But harnessing that information to benefit individual patients and prevent illnesses in others will require that doctors have access to genomic information for each patient. As health records are converted to digital form, the most likely place to store and retrieve genomic information will be Electronic Health Records (EHR). But when and how that happens will depend on having good models to build upon.

Now, in the first collection of its kind, the October 2013 issue of Genetics in Medicine, the official peer-reviewed journal of the American College of Medical Genetics and Genomics, provides a series of research articles detailing challenges and solutions for integrating genomic data into EHR. The issue features the insights of research teams actively engaged in integrating genomic medicine into clinical care. Most of the contributions derive from the experiences of individual sites that comprise the Electronic Medical Records and Genomics (eMERGE) Network, a national consortium funded by the National Institutes of Health, but additional perspective is provided by a commercial EHR vendor and by the Clinical Sequencing Exploratory Research (CSER) consortium, a cooperative group exploring applications of genomic sequencing.

"Our hope is that this issue of Genetics in Medicine will serve as a 'how to' and 'what to think about' for any group tasked with launching a genomics program and integrating this data into the EHR at the point of care," said Joseph Kannry, MD, a board-certified internist and Lead Technical Informaticist of the Epic Clinical Transformation Group, Mount Sinai Medical Center, New York, NY. "This issue should serve as a reference point for many years to come."

Dr. Kannry and co-editor Marc Williams, MD FACMG, director of the Genomic Medicine Institute, Geisinger Health System, Danville, Pa., steered the effort to organize contributions and together wrote the lead editorial. In it they state that, "Successfully integrating genomics into clinical care requires a vision, a strategy that will achieve the vision, and an actionable implementation plan." The case studies provided in this special issue outline the following challenges and potential solutions:

How can genomics be meaningfully incorporated into routine healthcare? [Hartzler et al. doi: GIM.2013.127] describe how a broad range of parties, including institutional leadership, physicians, information technology staff, and patients must be included in the conversation if genomic medicine is to be successful. The article describes different ways to ensure support systems are in place when launching a genomic medicine project.

How will genomic data be stored, processed, updated and retrieved? [citation: Kho et al. doi: GIM.2013.131] examine data currently captured in EHR systems and compare that to genomic data. They look forward to the need for long-term storage and retrieval and how data can be accessed and compared across time and in changing clinical circumstances.

Likewise, [Chute et al. doi: gim.2013.121] discuss the opportunities for large data sets of genomic information to help detect new genomic risk factors and clinically important information not possible until recently. They identify gaps in standards for coding and transmission of data and propose solutions.

See original here:

Genetics in Medicine publishes special issue dedicated to genomics in electronic health records

BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the …

WALTHAM, Mass., Sept. 19, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders announced today a series of events related to galectin-3 and heart failure during the 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) taking place on September 22nd-25th, 2013 in Orlando, Florida.

On Sunday, September 22nd, immediately following the opening session, BG Medicine will co-sponsor an Early Career Professionals Reception with Boston Scientific Corporation. This event provides a rare opportunity for early career professionals to meet mentors and talk with some of the most respected heart failure specialists in America.

Galectin-3 will be featured in several oral presentations at the meeting including one entitled, "Novel Biomarkers for Heart Failure -- Eventual Targets for Therapy" on Monday, September 23rd at 4:00pm Eastern Time. Christopher deFilippi, MD, Associate Professor of Medicine at the University of Maryland will discuss Galectin-3 and the prognosis in heart failure during this presentation.

On Tuesday, September 24th, there will be a Galectin-3 presentation by Alan Maisel, MD, Professor of Medicine and Director of the Coronary Care Unit at the University of California San Diego and Michael Zile, MD, Principal Investigator at the Gazes Cardiac Research Institute and Professor of Medicine at Medical University in Charleston, South Carolina. The title of the program is "Development, progression and hospitalization for heart failure: targeting fibrosis" and will take place at 12:45pm Eastern Time in The Peabody Hotel Exhibit Hall. This program will address the role of Galectin-3, a marker implicated in cardiac fibrosis, in the development of heart failure (HF) and how to use a biomarker guided approach to identify patients at high risk for near term hospitalization and mortality.

About Galectin-3 Testing and Heart Failure

Galectin-3 has been implicated in a variety of biological processes important in the development and progression of heart failure. Higher levels of galectin-3 are associated with a more aggressive form of heart failure, which may make identification of high-risk patients using galectin-3 testing an important part of patient care. Galectin-3 testing may be useful in helping physicians determine which patients are at higher risk of death or hospitalization, including 30-day readmission. The BGM Galectin-3(R) blood test is to be used as an aid in assessing the prognosis of patients with chronic heart failure, in conjunction with clinical evaluation. For more information visit http://www.galectin-3.com

About BG Medicine, Inc.

BG Medicine, Inc. (BGMD) is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.BG-medicine.com. The BG Medicine Inc. logo is available for download here

Read more here:

BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the ...

Immigration Reform Now! Photo Campaign at Harvard Medical School – Video


Immigration Reform Now! Photo Campaign at Harvard Medical School
As physicians in training, current students at Harvard Medical School and Harvard School of Dental Medicine explored the intersection of disease and social f...

By: Harvard Medical School Latino Medical Student Association

More here:

Immigration Reform Now! Photo Campaign at Harvard Medical School - Video

Campbell University unveils its medical school

By Venita Jenkins Staff writer

Campbell University President Jerry Wallace had been waiting for this moment for four years.

"There it is," he said. "The beautiful Leon Levine Hall of Medical Science. It's already working to make a difference in our state."

On Thursday, university officials held a dedication and ribbon cutting for the new School of Osteopathic Medicine, the state's first new medical school in 35 years.

The school will train primary-care doctors to serve in rural communities and keep them in the state through partnerships with local and regional hospitals.

North Carolina ranks 34th in the nation for its number of primary-care physicians per capita. About 20 counties in the state are without a general surgeon, and 13 of those are east of Charlotte, according to university officials.

Students will train in the areas of primary care and family medicine, general surgery, pediatrics and psychiatry.

Classes began in the medical school in mid-August with 162 students.

Campbell's program will become the second-largest medical school in the state within four years, reaching 600 students in 2017, officials said.

The $35 million school features simulation labs that are similar to emergency rooms, intensive-care units and primary-care clinics. Computer-enhanced mannequins will mimic symptoms that students must diagnose.

See the article here:

Campbell University unveils its medical school

Liberty Center tops off summer of history

SESQUICENTENNIAL

LIBERTY CENTER, Ohio In the grand finale of its Sesquicentennial Summer, the village of Liberty Center will commemorate its 1863 beginnings with a fall festival Saturday.

With tributes already paid to the past during Founders Day and the Wheels of Time and to the future with Kids Day, the celebration this weekend turns to the present with 12 hours of activities, opening with breakfast at 7 a.m. at the Liberty/Washington fire station and closing with two performances of The Spirit of Liberty production.

Events in the downtown area include the public librarys book sale in the annex; the Garden Club flower show at Charlie s Liberty Caf; the work of local artists at Tyler Sharpes studio; a restored classic car and truck show in the Methodist Church parking lot; inflatables and a mini-train for kids, and vendors and craftsmens displays.

Visitors can take horse-drawn wagon rides, and the historic Wabash Depot will be open to visitors through the day.

On the hour, beginning at 11 a.m., the stage set up near the Gerald Grain Center will welcome the Henry County Chorale, the Delta Community Band, and single acts by Garry Cline and Shane Piasecki and Guest. A chicken barbecue, bingo, and a dunk tank are on tap as well.

The Bell Choir from St. Patricks church near Grand Rapids will be featured in a guest appearance with the multi-community cast of The Spirit of Liberty production, which focuses this year on the 150-year-history of the community with all-time American musical hits. Shows for this special sesquicentennial production begin at 4 and 5:30 p.m. In lieu of admission, free-will gifts will be accepted at intermission to benefit the Liberty Center Public Library and the Liberty Center Historical Society.

Follow this link:

Liberty Center tops off summer of history

Liberty Interactive Remains Neutral

We reaffirm our long-term Neutral recommendation on Liberty Interactive Corp. (LINTA). The company reported mixed financial results for the second quarter of 2013. Liberty Interactive currently has a Zacks Rank #3 (Hold).

Why Kept at Neutral?

We believe that the TV home shopping business will continue to flourish in the near future. The QVC segment of the company has successfully transformed itself into a powerful global brand, which may boost Liberty Interactives revenues in the double-digits. Management stated that its online sales will constitute more than 50% of the total revenue in the U.S. by 2014. Growing adoption of high-end smartphones in the U.S. is the main reason for revenue growth.

Moreover, Liberty Interactive currently holds about 22% of the equity and 57% of the total votes of all classes of common stock of TripAdvisor Inc. (TRIP). TripAdvisor is the worlds largest travel site, which allows users to post reviews of airlines, hotels, and vacation resorts throughout the world.

On Aug 2013, Liberty Interactive launched a new broadcast channel called QVC PLUS. This second channel currently airs all the live broadcasts (TV shows) of the existing QVC channel at a delay of three hours. Management has decided to introduce some special programming in the QVC PLUS channel in order to broaden QVCs offerings.

QVC PLUS is currently available to DIRECTV (DTV) customers. Moreover, QVC has entered into carriage deals with Time Warner Cable Inc. (TWC) and Bright House Networks.

Meanwhile, the stock price of Liberty Interactive has soared 35% in the last year and is trading at the high-end of its 52-week price range. We believe that the stock is currently fairly valued.

Read the rest here:

Liberty Interactive Remains Neutral

Campaign for Liberty’s Norm Singleton on Obamacare, Auditing the Fed, and the Libertarian Moment – Video


Campaign for Liberty #39;s Norm Singleton on Obamacare, Auditing the Fed, and the Libertarian Moment
"A lot of politicians will vote libertarian if that is how they think they remain politicians," says Norm Singleton, Vice President for Policy at Campaign fo...

By: ReasonTV

Read the original post:

Campaign for Liberty's Norm Singleton on Obamacare, Auditing the Fed, and the Libertarian Moment - Video